- Home
- EOD vs CVRX Comparison
EOD vs CVRX Comparison
Compare EOD & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOD
- CVRX
- Stock Information
- Founded
- EOD 2007
- CVRX 2000
- Country
- EOD United States
- CVRX United States
- Employees
- EOD N/A
- CVRX N/A
- Industry
- EOD Investment Managers
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EOD Finance
- CVRX Health Care
- Exchange
- EOD Nasdaq
- CVRX Nasdaq
- Market Cap
- EOD 245.0M
- CVRX 203.9M
- IPO Year
- EOD N/A
- CVRX 2021
- Fundamental
- Price
- EOD $5.68
- CVRX $8.03
- Analyst Decision
- EOD
- CVRX Buy
- Analyst Count
- EOD 0
- CVRX 7
- Target Price
- EOD N/A
- CVRX $14.00
- AVG Volume (30 Days)
- EOD 118.1K
- CVRX 190.8K
- Earning Date
- EOD 01-01-0001
- CVRX 10-28-2025
- Dividend Yield
- EOD 9.28%
- CVRX N/A
- EPS Growth
- EOD N/A
- CVRX N/A
- EPS
- EOD N/A
- CVRX N/A
- Revenue
- EOD N/A
- CVRX $54,652,000.00
- Revenue This Year
- EOD N/A
- CVRX $11.32
- Revenue Next Year
- EOD N/A
- CVRX $18.58
- P/E Ratio
- EOD N/A
- CVRX N/A
- Revenue Growth
- EOD N/A
- CVRX 23.11
- 52 Week Low
- EOD $3.73
- CVRX $4.30
- 52 Week High
- EOD $4.71
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- EOD 49.82
- CVRX 56.27
- Support Level
- EOD $5.64
- CVRX $7.22
- Resistance Level
- EOD $5.80
- CVRX $8.35
- Average True Range (ATR)
- EOD 0.04
- CVRX 0.37
- MACD
- EOD -0.00
- CVRX 0.04
- Stochastic Oscillator
- EOD 21.88
- CVRX 71.68
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.